These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27284439)

  • 1. Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.
    Zhang MX; Liu K; Wang FG; Wen XW; Song XL
    Mol Clin Oncol; 2016 Jun; 4(6):1031-1038. PubMed ID: 27284439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism in cytochrome P450 2E1 and alcoholic pancreatitis sus-ceptibility: a meta-analysis.
    Wu C; Wu D; Liu Y; Zhong Y
    Hippokratia; 2018; 22(2):60-67. PubMed ID: 31217677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
    Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
    PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.
    Su XL; Bin B; Cui HW; Ran MR
    Chin J Cancer Res; 2011 Jun; 23(2):107-11. PubMed ID: 23483202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
    Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.
    Wang FJ; Wang Y; Niu T; Lu WX; Sandford AJ; He JQ
    J Clin Pharm Ther; 2016 Jun; 41(3):334-40. PubMed ID: 27062377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
    Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
    BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
    Zhuo W; Zhang L; Wang Y; Ling J; Zhu B; Chen Z
    PLoS One; 2012; 7(11):e48265. PubMed ID: 23139769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
    Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
    Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
    Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
    Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
    Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
    Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.
    Leng WD; Zeng XT; Chen YJ; Duan XL; Niu YM; Long RP; Luo ZX
    Exp Ther Med; 2012 Nov; 4(5):938-948. PubMed ID: 23226753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
    Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
    Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
    Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.
    Yao K; Qin H; Gong L; Zhang R; Li L
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):253-259. PubMed ID: 27491320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
    Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
    Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
    Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
    Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li L; Wang H; Zhang C; Yin G; Zhu B
    Eur J Cancer; 2010 Mar; 46(4):758-64. PubMed ID: 20031389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.